Condividi

PSC- DS COPDefence 21 - An Adaptive Interventional Clinical Investigation to Evaluate the Efficacy and Safety of PolmonYDEFENCE in supporting the prevention of exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.

Obiettivi del progetto

Primary objective

  • To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations.

Secondary objectives 

  • To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations by standard therapy.
  • To evaluate the performance of PolmonYDEFENCE in supporting the prevention of exacerbations.
  • To evaluate the performance of PolmonYDEFENCE in improving the healthrelated quality of life (HRQoL).
  • To evaluate the safety and tolerability of PolmonYDEFENCE. • To evaluate patient’s satisfaction with PolmonYDEFENCE

Data di inizio e fine

Novembre 2021 - 2024

Responsabile del progetto

Simone Scarlata - Principal Investigator

Istituzione coordinatrice del progetto

Fondazione Policlinico Campus Bio Medico

Altre Istituzioni coinvolte

  • IRCCS San Raffaele  Pisana, Roma

Fonte/i di finanziamento

• SOFAR S.p.A
COLLEGAMENTI RAPIDI
L'Università Campus Bio-Medico di Roma promuove strutture integrate d'insegnamento e ricerca perseguendo come fine principale delle proprie attività il bene della persona.
magnifiercrossmenuchevron-downchevron-leftchevron-right